Cargando…

Future Directions in the Assessment of Axillary Lymph Nodes in Patients with Breast Cancer

Background and Objectives: Breast cancer (BC) is a leading cause of morbidity and mortality worldwide, and accurate assessment of axillary lymph nodes (ALNs) is crucial for patient management and outcomes. We aim to summarize the current state of ALN assessment techniques in BC and provide insights...

Descripción completa

Detalles Bibliográficos
Autores principales: Pesapane, Filippo, Mariano, Luciano, Magnoni, Francesca, Rotili, Anna, Pupo, Davide, Nicosia, Luca, Bozzini, Anna Carla, Penco, Silvia, Latronico, Antuono, Pizzamiglio, Maria, Corso, Giovanni, Cassano, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534800/
https://www.ncbi.nlm.nih.gov/pubmed/37763661
http://dx.doi.org/10.3390/medicina59091544
_version_ 1785112479550930944
author Pesapane, Filippo
Mariano, Luciano
Magnoni, Francesca
Rotili, Anna
Pupo, Davide
Nicosia, Luca
Bozzini, Anna Carla
Penco, Silvia
Latronico, Antuono
Pizzamiglio, Maria
Corso, Giovanni
Cassano, Enrico
author_facet Pesapane, Filippo
Mariano, Luciano
Magnoni, Francesca
Rotili, Anna
Pupo, Davide
Nicosia, Luca
Bozzini, Anna Carla
Penco, Silvia
Latronico, Antuono
Pizzamiglio, Maria
Corso, Giovanni
Cassano, Enrico
author_sort Pesapane, Filippo
collection PubMed
description Background and Objectives: Breast cancer (BC) is a leading cause of morbidity and mortality worldwide, and accurate assessment of axillary lymph nodes (ALNs) is crucial for patient management and outcomes. We aim to summarize the current state of ALN assessment techniques in BC and provide insights into future directions. Materials and Methods: This review discusses various imaging techniques used for ALN evaluation, including ultrasound, computed tomography, magnetic resonance imaging, and positron emission tomography. It highlights advancements in these techniques and their potential to improve diagnostic accuracy. The review also examines landmark clinical trials that have influenced axillary management, such as the Z0011 trial and the IBCSG 23-01 trial. The role of artificial intelligence (AI), specifically deep learning algorithms, in improving ALN assessment is examined. Results: The review outlines the key findings of these trials, which demonstrated the feasibility of avoiding axillary lymph node dissection (ALND) in certain patient populations with low sentinel lymph node (SLN) burden. It also discusses ongoing trials, including the SOUND trial, which investigates the use of axillary ultrasound to identify patients who can safely avoid sentinel lymph node biopsy (SLNB). Furthermore, the potential of emerging techniques and the integration of AI in enhancing ALN assessment accuracy are presented. Conclusions: The review concludes that advancements in ALN assessment techniques have the potential to improve patient outcomes by reducing surgical complications while maintaining accurate disease staging. However, challenges such as standardization of imaging protocols and interpretation criteria need to be addressed. Future research should focus on large-scale clinical trials to validate emerging techniques and establish their efficacy and cost-effectiveness. Over-all, this review provides valuable insights into the current status and future directions of ALN assessment in BC, highlighting opportunities for improving patient care.
format Online
Article
Text
id pubmed-10534800
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105348002023-09-29 Future Directions in the Assessment of Axillary Lymph Nodes in Patients with Breast Cancer Pesapane, Filippo Mariano, Luciano Magnoni, Francesca Rotili, Anna Pupo, Davide Nicosia, Luca Bozzini, Anna Carla Penco, Silvia Latronico, Antuono Pizzamiglio, Maria Corso, Giovanni Cassano, Enrico Medicina (Kaunas) Review Background and Objectives: Breast cancer (BC) is a leading cause of morbidity and mortality worldwide, and accurate assessment of axillary lymph nodes (ALNs) is crucial for patient management and outcomes. We aim to summarize the current state of ALN assessment techniques in BC and provide insights into future directions. Materials and Methods: This review discusses various imaging techniques used for ALN evaluation, including ultrasound, computed tomography, magnetic resonance imaging, and positron emission tomography. It highlights advancements in these techniques and their potential to improve diagnostic accuracy. The review also examines landmark clinical trials that have influenced axillary management, such as the Z0011 trial and the IBCSG 23-01 trial. The role of artificial intelligence (AI), specifically deep learning algorithms, in improving ALN assessment is examined. Results: The review outlines the key findings of these trials, which demonstrated the feasibility of avoiding axillary lymph node dissection (ALND) in certain patient populations with low sentinel lymph node (SLN) burden. It also discusses ongoing trials, including the SOUND trial, which investigates the use of axillary ultrasound to identify patients who can safely avoid sentinel lymph node biopsy (SLNB). Furthermore, the potential of emerging techniques and the integration of AI in enhancing ALN assessment accuracy are presented. Conclusions: The review concludes that advancements in ALN assessment techniques have the potential to improve patient outcomes by reducing surgical complications while maintaining accurate disease staging. However, challenges such as standardization of imaging protocols and interpretation criteria need to be addressed. Future research should focus on large-scale clinical trials to validate emerging techniques and establish their efficacy and cost-effectiveness. Over-all, this review provides valuable insights into the current status and future directions of ALN assessment in BC, highlighting opportunities for improving patient care. MDPI 2023-08-25 /pmc/articles/PMC10534800/ /pubmed/37763661 http://dx.doi.org/10.3390/medicina59091544 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Pesapane, Filippo
Mariano, Luciano
Magnoni, Francesca
Rotili, Anna
Pupo, Davide
Nicosia, Luca
Bozzini, Anna Carla
Penco, Silvia
Latronico, Antuono
Pizzamiglio, Maria
Corso, Giovanni
Cassano, Enrico
Future Directions in the Assessment of Axillary Lymph Nodes in Patients with Breast Cancer
title Future Directions in the Assessment of Axillary Lymph Nodes in Patients with Breast Cancer
title_full Future Directions in the Assessment of Axillary Lymph Nodes in Patients with Breast Cancer
title_fullStr Future Directions in the Assessment of Axillary Lymph Nodes in Patients with Breast Cancer
title_full_unstemmed Future Directions in the Assessment of Axillary Lymph Nodes in Patients with Breast Cancer
title_short Future Directions in the Assessment of Axillary Lymph Nodes in Patients with Breast Cancer
title_sort future directions in the assessment of axillary lymph nodes in patients with breast cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534800/
https://www.ncbi.nlm.nih.gov/pubmed/37763661
http://dx.doi.org/10.3390/medicina59091544
work_keys_str_mv AT pesapanefilippo futuredirectionsintheassessmentofaxillarylymphnodesinpatientswithbreastcancer
AT marianoluciano futuredirectionsintheassessmentofaxillarylymphnodesinpatientswithbreastcancer
AT magnonifrancesca futuredirectionsintheassessmentofaxillarylymphnodesinpatientswithbreastcancer
AT rotilianna futuredirectionsintheassessmentofaxillarylymphnodesinpatientswithbreastcancer
AT pupodavide futuredirectionsintheassessmentofaxillarylymphnodesinpatientswithbreastcancer
AT nicosialuca futuredirectionsintheassessmentofaxillarylymphnodesinpatientswithbreastcancer
AT bozziniannacarla futuredirectionsintheassessmentofaxillarylymphnodesinpatientswithbreastcancer
AT pencosilvia futuredirectionsintheassessmentofaxillarylymphnodesinpatientswithbreastcancer
AT latronicoantuono futuredirectionsintheassessmentofaxillarylymphnodesinpatientswithbreastcancer
AT pizzamigliomaria futuredirectionsintheassessmentofaxillarylymphnodesinpatientswithbreastcancer
AT corsogiovanni futuredirectionsintheassessmentofaxillarylymphnodesinpatientswithbreastcancer
AT cassanoenrico futuredirectionsintheassessmentofaxillarylymphnodesinpatientswithbreastcancer